Genkyotex
Manufacturing · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 Forum 218, Archamps, Auvergne-Rhone-Al...Phone Number
+33 561287060Website
www.genkyotex.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Genkyotex
Calliditas Therapeutics AB specializes in the development of innovative therapies, particularly focusing on the NOX inhibitor platform. Their products include setanaxib, aimed at addressing unmet medical needs. The company targets healthcare providers and patients in need of advanced treatment options. As a wholly owned subsidiary, they continue to expand their research and development efforts in the pharmaceutical sector.Explore more
Genkyotex Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Genkyotex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Genkyotex is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Genkyotex
Genkyotex, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Genkyotex had a recent Job posting/layoffs
Check if Genkyotex has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Genkyotex has new funding data
Earning: See what the market has to say on Genkyotex recently announced quarterly report
Product Launch: Get notified when Genkyotex launches new products
Recommended Actions
Reach out to Masked Content who joined Genkyotex as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Genkyotex is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Genkyotex is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Genkyotex.
Genkyotex Tech Stack
A closer look at the technologies used by Genkyotex
See more technologies
Genkyotex News & Media
Genkyotex: COMMUNIQUE DE PRESSE DU 9 SEPTEMBRE 2021
ARCHAMPS, France--(BUSINESS WIRE)--Regulatory News: Genkyotex (Paris:GKTX) (Brussels:GKTX) : Ce communiqué ne constitue pas une offre d’acquérir des titres ni une quelconque forme de démarchage. PRIX DE L’OFFRE : 2,85 euros par action Genkyotex SA COMPLEMENTS DE PRIX EVENTUELS : les actionnaires qui auront apporté leurs actions à l’Offre se verront remettre des droits à complément de prix éventuels dans les conditions décrites à la Section 1.4.5 de la Note en Réponse (« Compléments de PrixCOMMUNIQUE DE PRESSE DU 19 AOUT 2021 RELATIF AU DEPOT D’UN PROJET DE NOTE EN REPONSE A L’OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIRE INITIÉE PAR CALLIDITAS THERAPEUTICS AB ET VISANT LES ACTIONS DE LA SOCIÉTÉ GENKYOTEX
ARCHAMPS, France--(BUSINESS WIRE)--Regulatory News: Genkyotex (Paris:GKTX) (Brussels:GKTX) : Ce communiqué ne constitue pas une offre d'acquérir des titres ni une quelconque forme de démarchage L’offre décrite ci-après ne pourra être ouverte qu’une fois déclarée conforme par l’Autorité des marchés financiers et reconnue par l’Autorité belge des services et marchés financiers Le projet d’offre, le projet d’information et le projet de note en réponse restent soumis à l’examen de l’Autorité des MaGenkyotex Announces 2020 Annual Financial Results and Provides Corporate Update
Regulatory News: Genkyotex (Paris:GKTX) (Brussels:GKTX) (Euronext Paris & Brussels: FR0013399474 – GKTX), a biopharmaceutical company and the leadGenkyotex Provides Q4 Business Update and Reports Cash Position
Regulatory News: Genkyotex (Euronext Paris & Brussels: FR0013399474 – GKTX) (Paris:GKTX) (Brussels:GKTX), a biopharmaceutical company and the lead
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genkyotex
Sign Up For FreeTo access detailed company insights
Calliditas Therapeutics AB specializes in the development of innovative therapies, particularly focusing on the NOX inhibitor platform. Their products include setanaxib, aimed at addressing unmet medical needs. The company targets healthcare providers and patients in need of advanced treatment options. As a wholly owned subsidiary, they continue to... Read More
